Bharat Immunologicals shows prevailing Real Value of 23.8 per share. The current price of the firm is 24.6. At this time the firm appears to be fairly valued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Operating Margin of
(5.13)% and Return On Asset of (1.69)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
|Investment Horizon||30 Days Login to change|
Bharat Immunologicals Biologicals Corp Ltd is rated fifth in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 0.26 of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for Bharat Immunologicals Biologicals Corp Ltd is roughly 3.79
Bharat Immunologicals is not very volatile asset. Calculation of real value of Bharat Immunologicals is based on 1 month time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.